investorscraft@gmail.com

Intrinsic Value of Antares Pharma, Inc. (ATRS)

Previous Close$0.00
Intrinsic Value
Upside potential
Previous Close
$0.00
* Our model cannot be used “out of the box” for the valuation of this stock. You can still do your own valuation by changing the valuation input parameters.

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2021-12-31 and quarterly data as of 2022-03-31.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2022202320242025202620272028202920302031203220332034203520362037203820392040204120422043204420452046

INCOME STATEMENT

Revenue growth rate, %23.0NaN
Revenue, $184NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m118NaN
Operating income, $m66NaN
EBITDA, $m70NaN
Interest expense (income), $mNaN
Earnings before tax, $m62NaN
Tax expense, $m16NaN
Net income, $m46NaN

BALANCE SHEET

Cash and short-term investments, $m67NaN
Total assets, $m258NaN
Adjusted assets (=assets-cash), $m190NaN
Average production assets, $m39NaN
Working capital, $m115NaN
Total debt, $m20NaN
Total liabilities, $m82NaN
Total equity, $m176NaN
Debt-to-equity ratio0.112NaN
Adjusted equity ratio0.578NaN

CASH FLOW

Net income, $m46NaN
Depreciation, amort., depletion, $m4NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m37NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m11NaN
Free cash flow, $m25NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m115
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount